Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESMany Clinical Outcome Assessments (COAs) designed for use within Central Nervous System (CNS) indications, particularly clinician reported outcomes (ClinROs), were developed prior to the release of the 2009 FDA guidance relating to the use of patient reported outcome measures (PROMs) in clinical development and pre-dated the Patient-Focused Drug Development (PFDD) guidance. Consequently, they do not meet the current regulatory standards for outcome measures in clinical trials. The use of ClinROs as primary and secondary efficacy endpoints requires considerable effort to ensure (1) compliance with this guidance and (2) appropriate implementation of the selected ClinRO over the course of a trial.
Sponsors need to generate evidence to support the content validity and psychometric properties of a ClinRO and maintain sufficient inter- and intra-rater reliability in its implementation throughout the pivotal trial. Challenges can occur at any stage, putting clinical development programs at risk.
This webinar will provide insights on the current CNS-focused COA landscape, PFDD guidance, what this means for legacy COAs (most notably ClinROs), recommendations for improving detection of treatment benefits, and ensuring optimal COA endpoint protection.
Join our experts as we address the following questions:
Jean Paty
Vice President, Patient Centered Solutions,
IQVIA
Betsy Williams,
Director, Scientific Services, Patient Centered Solutions,
IQVIA
Stella Karantzoulis, PhD, ABPP-CN,
Senior Principal, Patient Centered Solutions,
IQVIA
Cristian Sirbu, PhD, PsyD, MSHI
Principal, Cronos, an IQVIA Business